The increased level of CCR5 and its ligands persisted at 44 days after stroke, suggesting that CCR5 was continuously activated with high concentrations of the ligands in the infarct area during the chronic phase (Figure 4b–f). This evidence concerns the gene CCR5 and Stroke.